A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)

Clinical trial NCT01195636 · COMPLETED

Trial details

NCT number: NCT01195636
Sponsor: Xenon Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia

Start date: 2010-08-01
Primary completion: 2011-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.